Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Juliane Medler
Institution:
Universitätsklinikum Würzburg
Observed institution:
Universitätsklinikum Würzburg
ORCID:
0000-0002-9882-8433
Observed ORCID:
0000-0002-9882-8433
OpenAlex ID:
A5022446406
Tumor necrosis factor receptor-2 (TNFR2): an overview of an emerging drug target
2019
·
Juliane Medler
, Harald Wajant
·
Expert Opinion on Therapeutic Targets
·
194
Single-molecule imaging reveals the oligomeric state of functional TNFα-induced plasma membrane TNFR1 clusters in cells
2020
·
Christos Karathanasis
, Juliane Medler
, et al.
·
Science Signaling
·
93
Tumor Necrosis Factor Receptor 2 (TNFR2): An Emerging Target in Cancer Therapy
2022
·
Juliane Medler
, Kirstin Kucka
, et al.
·
Cancers
·
66
PDF
TNFRSF receptor-specific antibody fusion proteins with targeting controlled FcγR-independent agonistic activity
2019
·
Juliane Medler
, Johannes Nelke
, et al.
·
Cell Death and Disease
·
47
PDF
A TNFR2-Specific TNF Fusion Protein With Improved In Vivo Activity
2022
·
Juan Gamboa Vargas
, Jennifer Wagner
, et al.
·
Frontiers in Immunology
·
29
PDF
Quantitative single-molecule imaging of TNFR1 reveals zafirlukast as antagonist of TNFR1 clustering and TNFα-induced NF-ĸB signaling
2020
·
Nadine Weinelt
, Christos Karathanasis
, et al.
·
Journal of Leukocyte Biology
·
26
PDF
Membrane lymphotoxin-α2β is a novel tumor necrosis factor (TNF) receptor 2 (TNFR2) agonist
2021
·
Kirstin Kucka
, Isabell Lang
, et al.
·
Cell Death and Disease
·
22
PDF
Junctional adhesion molecule C expression specifies a CD138low/neg multiple myeloma cell population in mice and humans
2021
·
Andreas Brandl
, Antonio G. Solimando
, et al.
·
Blood Advances
·
16
CD40- and 41BB-specific antibody fusion proteins with PDL1 blockade-restricted agonism
2022
·
Juliane Medler
, Kirstin Kucka
, et al.
·
Theranostics
·
15
PDF
CD40- and CD95-specific antibody single chain-Baff fusion proteins display BaffR-, TACI- and BCMA-restricted agonism
2020
·
Johannes Nelke
, Juliane Medler
, et al.
·
mAbs
·
13
Generic design principles for antibody-based tumour necrosis factor (TNF) receptor 2 (TNFR2) agonists with FcγR-independent agonism
2023
·
Mohamed A. Anany
, Stefanie Haack
, et al.
·
Theranostics
·
7
PDF
Analysis of FcγR-Dependent Agonism of Antibodies Specific for Receptors of the Tumor Necrosis Factor (TNF) Receptor Superfamily (TNFRSF)
2020
·
Juliane Medler
, Harald Wajant
·
Methods in molecular biology
·
4
Analysis of Ligand-Receptor Interactions Using Bioluminescent TNF Superfamily (TNFSF) Ligand Fusion Proteins
2020
·
Kirstin Kucka
, Juliane Medler
, et al.
·
Methods in molecular biology
·
4
Harnessing the Expression of TNFR2 on Tregs to Prevent Agvhd
2022
·
Juan Gamboa Vargas
, Carla Kanzler
, et al.
·
Blood
·
1
Corrigendum: A TNFR2-specific TNF fusion protein with improved in vivo activity
2023
·
Juan Gamboa Vargas
, Jennifer Wagner
, et al.
·
Frontiers in Immunology
PDF
Show more works
View as search
Works count:
15
Citation count:
537
H-index:
10
I10-index:
10
Year
Topic
Type